AU Stock MarketDetailed Quotes

CHM Chimeric Therapeutics Ltd

Watchlist
  • 0.006
  • 0.0000.00%
20min DelayMarket Closed Jan 8 16:00 AET
9.45MMarket Cap-0.33P/E (Static)

Chimeric Therapeutics Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense
-28.72%21.02M
71.54%29.49M
9.55%17.19M
15.69M
Selling and administrative expenses
-23.24%9.15M
30.50%11.92M
48.14%9.14M
--6.17M
-Selling and marketing expense
--212.76K
----
----
--148.69K
-General and administrative expense
-25.02%8.94M
30.50%11.92M
51.80%9.14M
--6.02M
Research and development costs
-31.80%9.19M
160.43%13.47M
36.94%5.17M
--3.78M
Depreciation amortization depletion
4.22%1.01M
1.64%965.35K
12.14%949.76K
--846.96K
-Depreciation and amortization
4.22%1.01M
1.64%965.35K
12.14%949.76K
--846.96K
Other operating expenses
-46.52%1.67M
61.95%3.12M
-60.63%1.93M
--4.9M
Operating profit
28.72%-21.02M
-71.54%-29.49M
-9.55%-17.19M
-15.69M
Net non-operating interest income (expenses)
71.79%-210.5K
-19.00%-746.28K
-19,310.40%-627.15K
-3.23K
Non-operating interest income
340.11%121.32K
112.41%27.57K
390.44%12.98K
--2.65K
Non-operating interest expense
-57.12%331.81K
20.89%773.85K
10,792.07%640.13K
--5.88K
Other net income (expenses)
80.49%8.71M
131.77%4.83M
889.33%2.08M
-263.79K
Special income (charges)
59.40%-994
-18.55%-2.45K
---2.07K
----
-Gain on sale of property,plant,equipment
59.40%-994
-18.55%-2.45K
---2.07K
----
Other non-operating income (expenses)
80.42%8.71M
131.66%4.83M
890.11%2.08M
---263.79K
Income before tax
50.72%-12.52M
-61.47%-25.41M
-4.11%-15.73M
-15.11M
Income tax
-89.57%9.68K
-43.31%92.82K
163.72K
0
Earnings from equity interest net of tax
Net income
50.86%-12.53M
-60.40%-25.5M
-5.19%-15.9M
-15.11M
Net income continuous operations
50.86%-12.53M
-60.40%-25.5M
-5.19%-15.9M
---15.11M
Noncontrolling interests
Net income attributable to the company
50.86%-12.53M
-60.40%-25.5M
-5.19%-15.9M
-15.11M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
50.86%-12.53M
-60.40%-25.5M
-5.19%-15.9M
-15.11M
Diluted earnings per share
69.44%-0.018
-33.26%-0.0589
42.68%-0.0442
-0.0771
Basic earnings per share
69.44%-0.018
-33.26%-0.0589
42.68%-0.0442
-0.0771
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024 (FY)Jun 30, 2023 (FY)Jun 30, 2022 (FY)Jun 30, 2021
Total revenue
Cost of revenue
Gross profit
Operating expense -28.72%21.02M 71.54%29.49M 9.55%17.19M 15.69M
Selling and administrative expenses -23.24%9.15M 30.50%11.92M 48.14%9.14M --6.17M
-Selling and marketing expense --212.76K ---- ---- --148.69K
-General and administrative expense -25.02%8.94M 30.50%11.92M 51.80%9.14M --6.02M
Research and development costs -31.80%9.19M 160.43%13.47M 36.94%5.17M --3.78M
Depreciation amortization depletion 4.22%1.01M 1.64%965.35K 12.14%949.76K --846.96K
-Depreciation and amortization 4.22%1.01M 1.64%965.35K 12.14%949.76K --846.96K
Other operating expenses -46.52%1.67M 61.95%3.12M -60.63%1.93M --4.9M
Operating profit 28.72%-21.02M -71.54%-29.49M -9.55%-17.19M -15.69M
Net non-operating interest income (expenses) 71.79%-210.5K -19.00%-746.28K -19,310.40%-627.15K -3.23K
Non-operating interest income 340.11%121.32K 112.41%27.57K 390.44%12.98K --2.65K
Non-operating interest expense -57.12%331.81K 20.89%773.85K 10,792.07%640.13K --5.88K
Other net income (expenses) 80.49%8.71M 131.77%4.83M 889.33%2.08M -263.79K
Special income (charges) 59.40%-994 -18.55%-2.45K ---2.07K ----
-Gain on sale of property,plant,equipment 59.40%-994 -18.55%-2.45K ---2.07K ----
Other non-operating income (expenses) 80.42%8.71M 131.66%4.83M 890.11%2.08M ---263.79K
Income before tax 50.72%-12.52M -61.47%-25.41M -4.11%-15.73M -15.11M
Income tax -89.57%9.68K -43.31%92.82K 163.72K 0
Earnings from equity interest net of tax
Net income 50.86%-12.53M -60.40%-25.5M -5.19%-15.9M -15.11M
Net income continuous operations 50.86%-12.53M -60.40%-25.5M -5.19%-15.9M ---15.11M
Noncontrolling interests
Net income attributable to the company 50.86%-12.53M -60.40%-25.5M -5.19%-15.9M -15.11M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 50.86%-12.53M -60.40%-25.5M -5.19%-15.9M -15.11M
Diluted earnings per share 69.44%-0.018 -33.26%-0.0589 42.68%-0.0442 -0.0771
Basic earnings per share 69.44%-0.018 -33.26%-0.0589 42.68%-0.0442 -0.0771
Dividend per share
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP
Heat List
AU
Overall
Symbol
Price
% Chg

No Data